Virtu Financial LLC Aligos Therapeutics, Inc. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

A detailed history of Virtu Financial LLC transactions in Aligos Therapeutics, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 12,306 shares of ALGS stock, worth $232,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,306
Holding current value
$232,583
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$0.35 - $1.07 $4,307 - $13,167
12,306 New
12,306 $4,000
Q2 2023

Jul 27, 2023
BUY
$0.89 - $1.36 $16,334 - $24,960
18,353 New
18,353 $18,000

Others Institutions Holding ALGS

# of Institutions
3
Shares Held
253K
Call Options Held
0
Put Options Held
0
View Full List

About Aligos Therapeutics, Inc.

ALGS Quotes by TradingView
  • Ticker ALGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,717,000
  • Market Cap $751M
  • Description
  • Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...
More about ALGS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email